Effectiveness of National Residential Smoking Cessation Program

Mi-Jeong Park, Young-Gyun Seo, Hye-Mi Noh, Yeol Kim, Jong Lull Yoon and Yu-Jin Paek
Additional contact information
Mi-Jeong Park: Department of Family Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong 18450, Korea
Young-Gyun Seo: Department of Family Medicine, Hallym University Sacred Heart Hospital, Anyang 14068, Korea
Hye-Mi Noh: Department of Family Medicine, Hallym University Sacred Heart Hospital, Anyang 14068, Korea
Yeol Kim: National Cancer Center, Division of Center for Cancer Prevention and Detection, Goyang 10408, Korea
Jong Lull Yoon: Department of Family Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong 18450, Korea
Yu-Jin Paek: Department of Family Medicine, Hallym University Sacred Heart Hospital, Anyang 14068, Korea

IJERPH, 2021, vol. 18, issue 18, 1-15

Abstract: We aimed to investigate the effectiveness of the Korean national five-day residential smoking cessation program and the factors affecting the long-term smoking cessation of participants. The residential smoking cessation program (2017–2018) recruited smokers with a smoking duration ? 20 years and who have attempted to quit smoking more than twice and/or smokers with chronic morbidities. Participants underwent an intensive intervention, including individual psychological therapy, group therapy, medical counseling, and pharmacotherapy. The 6-month continuous abstinence rate (CAR) was assessed via self-reports, the urine cotinine levels, and/or expired-air carbon monoxide levels. Logistic regression was used to analyze the adjusted odds ratio (aOR) to assess factors related to smoking cessation. Overall, 484 participants who completed the residential program and questionnaire were evaluated. The 3- and 6-month CAR were 81.82% and 63.22%, respectively. The aOR of 6-month continuous abstinence was lower among participants with severe nicotine dependence (aOR: 0.46, 95% confidence interval [CI]: 0.26–0.81) and higher among participants with combination therapy of varenicline with short-term nicotine replacement therapy (NRT) (aOR: 1.64, 95% CI: 1.07–2.51), with higher self-efficacy (aOR: 1.97, 95% CI: 1.15–3.37). The residential smoking cessation program was effective. High self-efficacy, combination therapy of varenicline with short-term NRT, and low nicotine dependence were associated with a high 6-month CAR.

Keywords: COVID-19; tobacco; smoking; abstinence; residential smoking cessation program; varenicline; nicotine replacement therapy; chronic morbidity; nicotine dependence; self-efficacy (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/18/18/9901/pdf (application/pdf)
https://www.mdpi.com/1660-4601/18/18/9901/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:18:y:2021:i:18:p:9901-:d:639532

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().